SLC23A2 and type 2 diabetes mellitus: When corrected, these data for multiple testing, significantly lowered SLC23A2 gene expression (fold change) in the T2DM vs. the CG (p < 0.05) and in the T2DM +DR vs. −DR (p < 0.05) was detected.